首页> 外文期刊>International journal of gynecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics >Comparative study of dexamethasone and ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic gynecologic surgery.
【24h】

Comparative study of dexamethasone and ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic gynecologic surgery.

机译:地塞米松和恩丹西酮在腹腔镜妇科手术中预防术后恶心和呕吐的比较研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To compare intravenous dexamethasone and ondansetron for the prophylaxis of postoperative nausea and vomiting (PONV), a main complaint that affects almost 40%-75% of patients undergoing laparoscopic gynecologic surgery. METHODS: In a prospective study, 93 women were divided into 3 groups receiving 4mg of dexamethasone, 8mg of dexamethasone, or 4mg of ondansetron. PONV score was used for assessment during the first 24hours after surgery. RESULTS: The incidence of PONV during the 24-hour postoperative period was highest in the ondansetron group (61%). In the first 3hours, the incidence of PONV in the ondansetron group was also higher: 51.6% as compared with 22.6% and 36.6% in the dexamethasone 4mg and 8mg groups, respectively. The overall incidence of PONV was highest in the first 3hours as compared with later time periods, and there was a linear trend in decreasing PONV among the groups (P=0.017). In the dexamethasone 4mg group, the request for a rescue antiemetic was significantly lower: 0% as compared with 6.7% and 16.1% in the dexamethasone 8mg and ondansetron 4mg groups, respectively. CONCLUSION: Dexamethasone was found to be an efficacious and cost-effective drug for the prophylaxis of PONV.
机译:目的:比较静脉地塞米松和恩丹西酮在预防术后恶心和呕吐(PONV)上的作用,PONV是主要的影响因素,几乎影响了接受腹腔镜妇科手术的患者的40%-75%。方法:在一项前瞻性研究中,将93名妇女分为3组,分别接受地塞米松4mg,地塞米松8mg或恩丹西酮4mg。 PONV评分用于术后头24小时的评估。结果:恩丹西酮组术后24小时PONV的发生率最高(61%)。在头3小时内,昂丹西酮组PONV的发生率也更高:51.6%,而地塞米松4mg和8mg组分别为22.6%和36.6%。与后几个时间段相比,PONV的总发病率在前3小时最高,并且各组之间PONV的下降呈线性趋势(P = 0.017)。在地塞米松4mg组中,对止吐药的需求明显降低:0%,而地塞米松8mg和恩丹西酮4mg组分别为6.7%和16.1%。结论:地塞米松被发现是预防PONV的一种有效且具有成本效益的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号